📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
SRF Q3 FY26 PAT Surges 60% YoY to ₹433 Cr; Announces ₹5/Share Interim Dividend
SRF reported a strong Q3 FY26 performance with consolidated revenue growing 6% YoY to ₹3,713 crore and PAT jumping 60% to ₹433 crore. The Chemicals business led growth with a 22% revenue increase to ₹1,825 crore, driven by record performance in Fluorochemicals and firm global HFC prices. Despite pricing pressures from Chinese competitors in Specialty Chemicals and Technical Textiles, the company maintained market share and improved operational efficiencies. The board approved a second interim dividend of ₹5 per share and a new ₹180 crore investment for a pharma intermediate plant at Dahej.
Key Highlights
Consolidated PAT expanded 60% YoY to ₹433 crore, while EBIT rose 23% to ₹653 crore with 18% margins.
Chemicals segment revenue grew 22% YoY to ₹1,825 crore, supported by record refrigerant gas volumes and firm HFC prices.
Approved a new ₹180 crore investment for a second pharma intermediate plant at Dahej, expected to be commissioned in 8 months.
Declared a second interim dividend of ₹5 per share, entailing a total cash outflow of ₹148.21 crore.
Recognized a ₹73 crore exceptional charge for labor code changes and a ₹99 crore tax credit from a favorable ITAT order.
💼 Action for Investors
Investors should find the strong recovery in the Chemicals segment and the strategic expansion into pharma intermediates encouraging. The stock remains a solid play on fluorochemicals and specialty chemicals, though monitoring Chinese pricing competition is essential.